Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: January 7, 2019
Context: The registrant is an emerging growth company. This filing serves as a Regulation FD disclosure regarding upcoming investor and analyst presentations.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural disclosure regarding the use of presentation materials rather than a financial results report.
Material Changes
No material financial changes or operational updates are detailed in the text of this filing. The document solely announces the intent to use specific presentation materials (Exhibit 99.1) for upcoming investor communications.
Guidance, Outlook, and Risks
- Management Commentary: Executive officers intend to use the material in Exhibit 99.1 ("OrthoPediatrics Corp. Investor Presentation dated January 2019") for upcoming presentations.
- Legal Status of Information: The information furnished under Item 7.01 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
- Risks/Contingencies: No specific risks or contingencies are disclosed in this text.
Key Facts for Investor Verification
- Verify the contents of Exhibit 99.1 (Investor Presentation dated January 2019) for actual financial data and strategic outlook, as this 8-K only references the exhibit.
- Confirm the company's status as an emerging growth company and its election not to use the extended transition period for new accounting standards.
- Note that the information in this specific filing is not incorporated by reference into other SEC filings.